Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (411-420 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|August 19, 2024
Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantationLorenzo Cillo, Anna Benedetta Dalla Palma, Stefania Ricci, et al.
Ejhaem|August 19, 2024
<i>"Fast but not so furious"</i>: A condensed step-up dosing schedule of teclistamab for relapsed/refractory multiple myelomaKevin C Graf, James A Davis, Alyssa Cendagorta, et al.
Ejhaem|August 19, 2024
Combination of reduced post-transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft-versus-host disease in human leukocyte antigen-haploidentical peripheral blood stem-cell transplantationToshiki Terao, Takumi Kondo, Makoto Nakamura, et al.
Ejhaem|August 19, 2024
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patientsMonique C Minnema, Kazem Nasserinejad, Ute Hegenbart, et al.
Ejhaem|August 19, 2024
Intravenous Immunoglobulin offers temporary improvement in acquired von Willebrand syndrome due to monoclonal gammopathy: A case reportKevin G Zablonski, Aarthi Rajkumar, Lalitha Nayak
Ejhaem|August 19, 2024
Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphomaTomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, et al.
Ejhaem|August 19, 2024
Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case reportAshwin Kannan, Ying Zhuo, Rahul Banerjee
Ejhaem|August 19, 2024
Sequential treatment with valemetostat and conventional anti-cancer drugs for refractory aggressive adult T-cell leukemia/lymphoma: A case reportKosuke Obama, Hana Yamamoto, Hirosaka Inoue
Ejhaem|August 19, 2024
Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective studyJieling Jiang, Xiaofan Li, Dong Wu, et al.
Ejhaem|October 17, 2024
Low-grade follicular lymphoma with interferon regulatory factor-4 rearrangement: Expanding the spectrum of interferon regulatory factor-4-rearranged lymphomasAli Sakhdari, Peter J B Sabatini, Tulasi Geevar, et al.
Pageof 93

Showing results (411-420 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|August 19, 2024
Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantationLorenzo Cillo, Anna Benedetta Dalla Palma, Stefania Ricci, et al.
Ejhaem|August 19, 2024
<i>"Fast but not so furious"</i>: A condensed step-up dosing schedule of teclistamab for relapsed/refractory multiple myelomaKevin C Graf, James A Davis, Alyssa Cendagorta, et al.
Ejhaem|August 19, 2024
Combination of reduced post-transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft-versus-host disease in human leukocyte antigen-haploidentical peripheral blood stem-cell transplantationToshiki Terao, Takumi Kondo, Makoto Nakamura, et al.
Ejhaem|August 19, 2024
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patientsMonique C Minnema, Kazem Nasserinejad, Ute Hegenbart, et al.
Ejhaem|August 19, 2024
Intravenous Immunoglobulin offers temporary improvement in acquired von Willebrand syndrome due to monoclonal gammopathy: A case reportKevin G Zablonski, Aarthi Rajkumar, Lalitha Nayak
Ejhaem|August 19, 2024
Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphomaTomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, et al.
Ejhaem|August 19, 2024
Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case reportAshwin Kannan, Ying Zhuo, Rahul Banerjee
Ejhaem|August 19, 2024
Sequential treatment with valemetostat and conventional anti-cancer drugs for refractory aggressive adult T-cell leukemia/lymphoma: A case reportKosuke Obama, Hana Yamamoto, Hirosaka Inoue
Ejhaem|August 19, 2024
Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective studyJieling Jiang, Xiaofan Li, Dong Wu, et al.
Ejhaem|October 17, 2024
Low-grade follicular lymphoma with interferon regulatory factor-4 rearrangement: Expanding the spectrum of interferon regulatory factor-4-rearranged lymphomasAli Sakhdari, Peter J B Sabatini, Tulasi Geevar, et al.
Pageof 93